In our EMFSA March 2025 Newsletter we look at what effect long term antibiotic treatments can have.

• Long term antibiotic use for chronic Lyme treatments
• Did individuals receive sufficiently transparent informed consent?
• Can misdiagnosis occur?
• What additional testing methods are available to assist patients and medical practitioners?
• The risk of missing a serious illness.
• Long term financial output and personal cost.

RF-EMFs can interfere with active implants.

The International Commission on Non-Ionizing Radiation Protection (ICNIRP) acknowledges that RF-EMFs can interfere with active implants. ICNIRP considers such exposures outside the scope of its guidelines. This means that the responsibility falls on pacemaker manufacturers and patients’ medical providers.

Pacemakers

Individuals with active pacemakers should keep their distance from an active microwave. Patients and doctors should take note of this advice.

The Frontiers Research Topic on Individual Sensitivity to Wireless Radiation

The Research Topic now contains 5 articles, with the first article published in 2024. Since 2024 these articles have been open access and freely available to everyone. Read more about the latest opinion article and the conclusions of the author, who himself is Electrohypersensitive (EHS).

“All in your head“

The “All in your head” mantra—what are the consequences of such hurtful and dismissive statements?

Why is the French Agency for Food, Environmental and Occupational Health & Safety (ANSES) concerned about food supplements containing Garcinia cambogia? Noteworthy is that ANSES commissioned an expert assessment to take stock of the adverse effects caused by the consumption of Garcinia cambogia Desr-based food supplements.

Read about the advice Linda S. Birnbaum, Scientist Emeritus and Former Director of the National Institute of Environmental Health Sciences has for the essential oil industry.

Nestled in the Blaeberry Valley of Golden, BC, this unique, spiritual, and peaceful riverside retreat offers a chance to reconnect with nature. As you immerse yourself in the surroundings, you’ll nourish your being and feel empowered by the mountains.

Link to our March 2025 Newsletter https://mailchi.mp/emfsa/emfsa-march-2025-newsletter-chronic-lyme

We send our newsletter only once a month. Want to stay updated? Subscribe today! Newsletter – EMFSA

The post EMFSA March 2025 Newsletter appeared first on EMFSA.

Link to our free October 2024 Newsletter https://mailchi.mp/emfsa/ehs-cfs-me

The post EMFSA October 2024 Newsletter appeared first on EMFSA.

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Electrohypersensitivity (EHS)
Both ME/CFS and EHS are chronic health conditions that profoundly impact individuals’ lives. Yet, despite their debilitating effects, both remain under-researched and misunderstood, leaving many without proper care or recognition.

Shared Challenges
Impaired Functioning: People are not able to function the same way they did before they became ill.
Impact on Daily Life: Employment, social and family life are affected.
Long-Term Chronic Effects: It can last for years and may lead to a serious disability.
Mental Health Misconceptions: Often dismissed as psychological in origin.
Lack of Support: Limited healthcare access and research.

These conditions are challenging to diagnose due to the lack of specific tests. While ME/CFS has received more research attention and has established diagnostic guidelines, EHS lacks similar clarity.

Historical and Ongoing Medical Dismissal
ME/CFS has had a long and complex history in terms of medical recognition, especially regarding its classification as a physical versus a mental condition. The shift from viewing it as primarily psychological to recognizing it as a physical illness occurred gradually and varied by country and medical organizations.

Today, ME/CFS is recognized as a legitimate physical illness by major health organizations, including the CDC, the NIH, and the WHO. However, challenges remain regarding diagnosis, treatment, and public perception. Healthcare access is still limited, and many in the medical community rely on outdated information. In some cases cognitive behavioural therapy and graded exercise continue to be prescribed for ME/CFS even though these treatments have been shown to worsen the condition.

Similarly, the WHO continues to recommend that treatment for EHS should exclude addressing the person’s “perceived” need to reduce or eliminate EMF exposure at home or in the workplace. This recommendation may be putting people at risk. **Please see the disclaimer at the bottom of the post.

The tragic case of Maeve Boothby O’Neill
Maeve Boothby O’Neill’s death serves as a stark reminder of the harm caused by discredited views on ME/CFS.
As journalist George Monbiot asks, “How was this allowed to happen?”
https://www.theguardian.com/commentisfree/2024/oct/18/maeve-bothby-oneill-me-chronic-fatigue-syndrome

Care for people with severe ME is “nonexistent,” says coroner in call to action.
The hard hitting prevention of future deaths report by assistant coroner Deborah Archer on the death of Maeve Boothby O’Neill, 27, also highlighted the lack of research funding, training, and guidelines on treating ME. https://www.bmj.com/content/387/bmj.q2202

The Struggle for EHS Recognition
Similar to ME/CFS, efforts to gain recognition for Electrohypersensitivity (EHS) as a legitimate physical illness is ongoing. Dismissive attitudes, such as those expressed by the 2020 Chair of ICNIRP, negatively impact how the medical community, research funders, and regulatory bodies perceive the condition. Dismissing or ridiculing individuals with EHS is not only cruel and disrespectful but also poses a real threat to public health by undermining the seriousness of the condition and stalling research efforts.
https://www.emfsa.co.za/ehs/icnirps-chair-rodney-croft-electrohypersensitivity/

Professor Croft is a member of ICNIRP’s Scientific Expert Group https://www.icnirp.org/en/about-icnirp/scientific-expert-group/index.html

Call for Multidisciplinary Research
In our experience, it is common for individuals to exhibit symptoms of both EHS and ME/CFS, often due to heightened sensitivity to environmental factors. This overlap underscores the urgent need for global, multidisciplinary research efforts. Well coordinated studies and the development of effective solutions should be prioritized as part of public health initiatives to improve the quality of life for those affected by these conditions.

“The WHO should recognize EHS as a probable health impairment to stimulate the currently stagnant, but urgently needed, research on individual sensitivity to RF-EMF” Dariusz Leszczynski, PhD, DSc. Adjunct Professor of Biochemistry, University of Helsinki, Finland, and Chief Editor ‘Radiation and Health’, Frontiers in Public Health, Lausanne, Switzerland; https://betweenrockandhardplace.wordpress.com/wp-content/uploads/2024/10/final-leszczynski-poster-ehs-diagnosis.pdf

We thank Dave Ashton from UK Electosensitives for his input.

** Disclaimer: EMFSA is a radiation protection consultancy, offering advice and services to
assist individuals reduce EMF exposure in their homes and workplaces.

References
Ref. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness, Military Medicine, Volume 180, Issue 7, July 2015, Pages 721–723, https://doi.org/10.7205/MILMED-D-15-00085
CDC https://www.cdc.gov/me-cfs/about/index.html
NIH https://www.nih.gov/mecfs/about-mecfs
WHO https://www.who.int/standards/classifications/frequently-asked-questions/chronic-fatigue-syndrome

The post ME/CFS and EHS – The Struggle for Research and Recognition appeared first on EMFSA.

According to the Times of Israel, Israel’s National Insurance Institute is now to recognize fibromyalgia as a disability.

The rights are extended to sufferers of Chronic Fatigue Syndrome (CFS), a related condition.

Sources:

https://www.timesofisrael.com/israel-to-recognize-fibromyalgia-a-chronic-muscle-pain-illness-as-a-disability/

The post Fibromyalgia and CFS categorized as disabilities in Israel appeared first on EMFSA.